RT53M

General Information


DRACP ID  DRACP05896

Peptide Name   RT53M

Sequence  RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGGQVYIRQGRLALQGKT

Sequence Length  53

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce necrosis



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C298H487N93O69S

Absent amino acids  CHPS

Common amino acids  K

Mass  743650

Pl  12.21

Basic residues  16

Acidic residues  2

Hydrophobic residues  19

Net charge  14

Boman Index  -14402

Hydrophobicity  -93.58

Aliphatic Index  79.25

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  13980

Absorbance 280nm  268.85

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30080874

Title  The anticancer peptide RT53 induces immunogenic cell death

Doi 10.1371/journal.pone.0201220

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.